Advanced search
1 file | 764.12 KB Add to list

The financial impact of SBRT for oligometastatic disease : a population-level analysis in Belgium

(2020) RADIOTHERAPY AND ONCOLOGY. 145. p.215-222
Author
Organization
Keywords
Oncology, Radiology Nuclear Medicine and imaging, Hematology, LUNG-CANCER, RADIOTHERAPY, COST, THERAPY, EUROPE, ACCESS

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 764.12 KB

Citation

Please use this url to cite or link to this publication:

MLA
Nevens, Daan, et al. “The Financial Impact of SBRT for Oligometastatic Disease : A Population-Level Analysis in Belgium.” RADIOTHERAPY AND ONCOLOGY, vol. 145, 2020, pp. 215–22, doi:10.1016/j.radonc.2020.01.024.
APA
Nevens, D., Kindts, I., Defourny, N., Boesmans, L., Van Damme, N., Engels, H., … Lievens, Y. (2020). The financial impact of SBRT for oligometastatic disease : a population-level analysis in Belgium. RADIOTHERAPY AND ONCOLOGY, 145, 215–222. https://doi.org/10.1016/j.radonc.2020.01.024
Chicago author-date
Nevens, Daan, Isabelle Kindts, Noémie Defourny, Leen Boesmans, Nancy Van Damme, Hilde Engels, Carine Van de Voorde, and Yolande Lievens. 2020. “The Financial Impact of SBRT for Oligometastatic Disease : A Population-Level Analysis in Belgium.” RADIOTHERAPY AND ONCOLOGY 145: 215–22. https://doi.org/10.1016/j.radonc.2020.01.024.
Chicago author-date (all authors)
Nevens, Daan, Isabelle Kindts, Noémie Defourny, Leen Boesmans, Nancy Van Damme, Hilde Engels, Carine Van de Voorde, and Yolande Lievens. 2020. “The Financial Impact of SBRT for Oligometastatic Disease : A Population-Level Analysis in Belgium.” RADIOTHERAPY AND ONCOLOGY 145: 215–222. doi:10.1016/j.radonc.2020.01.024.
Vancouver
1.
Nevens D, Kindts I, Defourny N, Boesmans L, Van Damme N, Engels H, et al. The financial impact of SBRT for oligometastatic disease : a population-level analysis in Belgium. RADIOTHERAPY AND ONCOLOGY. 2020;145:215–22.
IEEE
[1]
D. Nevens et al., “The financial impact of SBRT for oligometastatic disease : a population-level analysis in Belgium,” RADIOTHERAPY AND ONCOLOGY, vol. 145, pp. 215–222, 2020.
@article{8664526,
  author       = {{Nevens, Daan and Kindts, Isabelle and Defourny, Noémie and Boesmans, Leen and Van Damme, Nancy and Engels, Hilde and Van de Voorde, Carine and Lievens, Yolande}},
  issn         = {{0167-8140}},
  journal      = {{RADIOTHERAPY AND ONCOLOGY}},
  keywords     = {{Oncology,Radiology Nuclear Medicine and imaging,Hematology,LUNG-CANCER,RADIOTHERAPY,COST,THERAPY,EUROPE,ACCESS}},
  language     = {{eng}},
  pages        = {{215--222}},
  title        = {{The financial impact of SBRT for oligometastatic disease : a population-level analysis in Belgium}},
  url          = {{http://dx.doi.org/10.1016/j.radonc.2020.01.024}},
  volume       = {{145}},
  year         = {{2020}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: